BioMade, a Defense Department-sponsored Manufacturing Innovation Institute launched in 2021, will work with Lygos, a sustainable specialty chemicals company, to transition its pilot-scale biomanufacturing infrastructure at 25821 Industrial Blvd. in Hayward into a nationally available, multi-user facility. BioMade will independently operate the pilot-scale facility as the second announced site in its national network.
The San Francisco Business Times reported that the U.S. bioindustrial manufacturing industry faces a scale-up challenge due to a lack of infrastructure, which often pushes American companies to seek manufacturing facilities overseas.
“This facility will play a critical role as America works to regain dominance in the biotechnology and biomanufacturing industry,” said Douglas Friedman, CEO of BioMade. “Other countries around the world have been investing in biotechnology for decades, and the U.S. is at risk of falling behind. Expanding nationwide capabilities to produce chemicals and materials needed for defense and consumer applications will strengthen national security and secure domestic supply chains.”
The Hayward facility is one of 12 that BioMADE aims to establish nationwide, and the only one to be located in California.
The post BioMade, Lygos to Establish Multi-User Biomanufacturing in Hayward appeared first on Connect CRE.
